Access to unpublished protocols and statistical analysis plans of randomised trials

被引:3
|
作者
Campbell, David [1 ]
McDonald, Cassandra [1 ]
Cro, Suzie [2 ]
Jairath, Vipul [1 ,3 ]
Kahan, Brennan C. [4 ]
机构
[1] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada
[2] Imperial Coll London, Imperial Clin Trials Unit, London, England
[3] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[4] UCL, MRC Clin Trials Unit, London, England
基金
美国国家卫生研究院;
关键词
Randomised trials; Protocols; Statistical analysis plans; Data sharing; Unpublished protocols; AVAILABILITY;
D O I
10.1186/s13063-022-06641-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigators would share unavailable documents upon request. Methods We used trials from two previously identified cohorts (cohort 1: 101 trials published in high impact factor journals between January and April of 2018; cohort 2: 100 trials published in June 2018 in journals indexed in PubMed) to determine whether study investigators would share unavailable protocols/SAPs upon request. We emailed corresponding authors of trials with no publicly available protocol or SAP up to four times. Results Overall, 96 of 201 trials (48%) across the two cohorts had no publicly available protocol or SAP (11/101 high-impact cohort, 85/100 PubMed cohort). In total, 8/96 authors (8%) shared some trial documentation (protocol only [n = 5]; protocol and SAP [n = 1]; excerpt from protocol [n = 1]; research ethics application form [n = 1]). We received protocols for 6/96 trials (6%), and a SAP for 1/96 trial (1%). Seventy-three authors (76%) did not respond, 7 authors responded (7%) but declined to share a protocol or SAP, and eight email addresses were invalid (8%). A total of 329 emails were sent (an average of 41 emails for every trial which sent documentation). After emailing authors, the total number of trials with an available protocol increased by only 3%, from 52% in to 55%. Conclusions Most study investigators did not share their unpublished protocols or SAPs upon direct request. Alternative strategies are needed to increase transparency of randomised trials and ensure access to protocols and SAPs.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Access to unpublished protocols and statistical analysis plans of randomised trials
    David Campbell
    Cassandra McDonald
    Suzie Cro
    Vipul Jairath
    Brennan C. Kahan
    [J]. Trials, 23
  • [2] Statistical analysis plans for internal pilots in randomised controlled trials
    McDowell, Cliona
    Gardner, Evie
    Harrison, David
    McNamee, James
    McAuley, Daniel F.
    [J]. TRIALS, 2017, 18
  • [3] Prospective reporting of statistical analysis plans for randomised controlled trials
    Karla Hemming
    Anna Kearney
    Carrol Gamble
    Tianjing Li
    Peter Jüni
    An-Wen Chan
    Matthew R. Sydes
    [J]. Trials, 21
  • [4] Prospective reporting of statistical analysis plans for randomised controlled trials
    Hemming, Karla
    Kearney, Anna
    Gamble, Carrol
    Li, Tianjing
    Juni, Peter
    Chan, An-Wen
    Sydes, Matthew R.
    [J]. TRIALS, 2020, 21 (01)
  • [5] Statistical Analysis Plans for Clinical Trials
    Cesana, Bruno Mario
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1938 - 1938
  • [6] Bayesian interim statistical analysis of randomised trials
    Brophy, JM
    Joseph, L
    [J]. LANCET, 1997, 349 (9059): : 1166 - 1168
  • [7] Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
    Gamble, Carrol
    Krishan, Ashma
    Stocken, Deborah
    Lewis, Steff
    Juszczak, Edmund
    Dore, Caroline
    Williamson, Paula R.
    Altman, Douglas G.
    Montgomery, Alan
    Lim, Pilar
    Berlin, Jesse
    Senn, Stephen
    Day, Simon
    Barbachano, Yolanda
    Loder, Elizabeth
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (23): : 2337 - 2343
  • [8] Development of guidance for statistical analysis plans (SAPs) for clinical trials
    Ashma Krishan
    Deborah Stocken
    Steff Lewis
    Ed Juszczak
    Caroline Dore
    Paula Williamson
    Doug Altman
    Alan Montgomery
    Mike Clarke
    Carrol Gamble
    [J]. Trials, 16
  • [9] Development of guidance for statistical analysis plans (SAPs) for clinical trials
    Krishan, Ashma
    Stocken, Deborah
    Lewis, Steff
    Juszczak, Ed
    Dore, Caroline
    Williamson, Paula
    Altman, Doug
    Montgomery, Alan
    Clarke, Mike
    Gamble, Carrol
    [J]. TRIALS, 2015, 16
  • [10] Statistical analysis of Goal Attainment Scaling endpoints in randomised trials
    Urach, S.
    Gaasterland, C. M. W.
    Posch, M.
    Jilma, B.
    Roes, K.
    Rosenkranz, G.
    Van der Lee, J. H.
    Ristl, R.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (06) : 1893 - 1910